Sign In

Oliver Thiel

Vice President, Process Development

Oliver Thiel is a highly accomplished executive in the pharmaceutical industry, currently serving as Vice President of Process Development at Amgen.3 Here's an overview of his background and career:

Education and Early Career

Oliver Thiel holds a diverse educational background, including:

  • Master's degree in Chemistry from the Technical University of Munich
  • Ph.D. from the Max-Planck-Institut für Kohlenforschung
  • Business degree from Fernuniversität Hagen
  • Postdoctoral fellowship at Stanford University1

Career at Amgen

Thiel joined Amgen in 2003 and has spent over two decades with the company.4 Throughout his tenure, he has held various positions in Process Development, showcasing his expertise and leadership skills:

  • Currently serves as Vice President of Process Development and Operations Commercialization1
  • Previously held the role of Associate Vice President of Drug Substance Technologies Synthetics1
  • Executive Director of Process Development, Drug Substance Technologies Pivotal, and Commercial Synthetics

Responsibilities and Achievements

In his current role, Thiel leads the delivery of operations' product strategies and commitments for commercialization at Amgen.1 His teams have been responsible for:

  • Commercial process development
  • Technology transfers
  • Commercial support for existing products
  • Clinical development of new candidates1

Thiel has contributed significantly to the field of pharmaceutical manufacturing and green chemistry. He emphasizes the importance of minimizing environmental impact while maintaining cost-effectiveness in production processes.2

Professional Contributions

Oliver Thiel has made notable contributions to the scientific community:

  • Authored more than 50 publications
  • Presented at international conferences
  • Serves on the ICH M7 Expert Working Group
  • Engaged in workstreams from the American Chemical Society and the IQ consortium1

Awards and Recognition

Thiel's expertise and contributions have been recognized through various honors, including:

  • Feodor-Lynen-Postdoctoral Fellowship from the Alexander von Humboldt Society in 2001
  • Invited speaker at the ACS Young Industrial Investigator symposium in 20093

Oliver Thiel's LinkedIn username is oliver-thiel-5338241, as mentioned in the query.

Highlights

Oct 22 · capra.ca
CAPRA 2024 Pharmaceutical SYMPOSIUM
Oct 18 · amgen.com
“Green” Chemistry Makes Pharmaceutical Manufacturing Better for ...

Related Questions

What are some of the key projects Oliver Thiel has led at Amgen?
How has Oliver Thiel contributed to the development of drugs like Enbrel and Neulasta?
What is Oliver Thiel's role in the ICH M7 Expert Working Group?
Can you provide more details about Oliver Thiel's work in green chemistry?
What are some of the patents Oliver Thiel is an inventor on?
Oliver Thiel
Oliver Thiel, photo 1
Oliver Thiel, photo 2
Add to my network

Location

Cambridge, Massachusetts, United States